ascopubs.org2d
Implementation of hereditary cancer risk assessment in primary care: Intervention strategies and proximal outcomes.
Evolution of overall survival (OS) after curative-intent lung cancer surgery in a population-based Mississippi Delta cohort. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium.
ascopubs.org5d
Perioperative interventions to enhance surgical outcomes for older adults with cancer: A systematic review.
A phase 2/3 study of romiplostim N01 in chemotherapy-induced thrombocytopenia (CIT). Baseline characteristics of parents enrolled in ACCL20N1CD: Financial distress during treatment for pediatric acute ...
ascopubs.org6d
Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
ascopubs.org6d
Reply to C. Fuchao et al
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
ascopubs.org6d
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
ascopubs.org6d
Erratum: CML and the WHO: Why?
The March 20, 2024, article by Berman et al entitled “CML and the WHO: Why?” (J Clin Oncol 10.1200/JCO.23.01689) was published with an error. In the author list ...
ascopubs.org6d
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
ascopubs.org6d
Navigating financial risk: Unlocking the power of modeling and risk quantification in episode-based payment models.
Optimizing clinical research in a regional cancer center network: A multidepartment survey-based approach. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This abstract ...
ascopubs.org6d
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005 The study cohort consisted ...
ascopubs.org6d
Using a Polygenic Risk Score to Improve the Risk Prediction of Non–Small Cell Lung Cancer in Taiwan
Comprehensive Genomic Analysis of Patients With Non–Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan We studied a ...
ascopubs.org7d
Impact of Cancer Across the Intergenerational Family: A Multidimensional Perspective From African Countries
This commentary explores the intergenerational (affecting and involving multiple generations) harm caused by cancer and cancer-related deaths in African countries, particularly cancer and ...